ID   CLC4A_HUMAN             Reviewed;         237 AA.
AC   Q9UMR7; Q17R69; Q8WXW9; Q9H2Z9; Q9NS33; Q9UI34;
DT   15-FEB-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   03-AUG-2022, entry version 173.
DE   RecName: Full=C-type lectin domain family 4 member A {ECO:0000305};
DE   AltName: Full=C-type lectin DDB27;
DE   AltName: Full=C-type lectin superfamily member 6;
DE   AltName: Full=Dendritic cell immunoreceptor;
DE   AltName: Full=Lectin-like immunoreceptor;
DE   AltName: CD_antigen=CD367;
GN   Name=CLEC4A {ECO:0000312|HGNC:HGNC:13257};
GN   Synonyms=CLECSF6 {ECO:0000303|PubMed:27015765}, DCIR
GN   {ECO:0000303|PubMed:27015765}, LLIR; ORFNames=HDCGC13P;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY, AND
RP   INDUCTION.
RX   PubMed=10438934;
RA   Bates E.E.M., Fournier N., Garcia E., Valladeau J., Durand I., Pin J.-J.,
RA   Zurawski S.M., Patel S., Abrams J.S., Lebecque S., Garrone P., Saeland S.;
RT   "APCs express DCIR, a novel C-type lectin surface receptor containing an
RT   immunoreceptor tyrosine-based inhibitory motif.";
RL   J. Immunol. 163:1973-1983(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 3 AND 4), INTERACTION WITH PTPN6,
RP   TISSUE SPECIFICITY, ALTERNATIVE SPLICING, AND VARIANT LEU-36.
RX   PubMed=11178971; DOI=10.1006/bbrc.2001.4322;
RA   Huang X., Yuan Z., Chen G., Zhang M., Zhang W., Yu Y., Cao X.;
RT   "Cloning and characterization of a novel ITIM containing lectin-like
RT   immunoreceptor LLIR and its two transmembrane region deletion variants.";
RL   Biochem. Biophys. Res. Commun. 281:131-140(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), TISSUE SPECIFICITY,
RP   INDUCTION, AND VARIANT LEU-36.
RX   PubMed=11994513;
RA   Richard M., Veilleux P., Rouleau M., Paquin R., Beaulieu A.D.;
RT   "The expression pattern of the ITIM-bearing lectin CLECSF6 in neutrophils
RT   suggests a key role in the control of inflammation.";
RL   J. Leukoc. Biol. 71:871-880(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT LEU-36.
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, TISSUE SPECIFICITY, INDUCTION BY TRL9, AND SUBCELLULAR LOCATION.
RX   PubMed=18258799; DOI=10.1182/blood-2007-03-081398;
RA   Meyer-Wentrup F., Benitez-Ribas D., Tacken P.J., Punt C.J., Figdor C.G.,
RA   de Vries I.J., Adema G.J.;
RT   "Targeting DCIR on human plasmacytoid dendritic cells results in antigen
RT   presentation and inhibits IFN-alpha production.";
RL   Blood 111:4245-4253(2008).
RN   [7]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=20530286; DOI=10.1182/blood-2010-01-264960;
RA   Klechevsky E., Flamar A.L., Cao Y., Blanck J.P., Liu M., O'Bar A.,
RA   Agouna-Deciat O., Klucar P., Thompson-Snipes L., Zurawski S., Reiter Y.,
RA   Palucka A.K., Zurawski G., Banchereau J.;
RT   "Cross-priming CD8+ T cells by targeting antigens to human dendritic cells
RT   through DCIR.";
RL   Blood 116:1685-1697(2010).
RN   [8]
RP   FUNCTION (MICROBIAL INFECTION), AND MUTAGENESIS OF THR-6 AND TYR-7.
RX   PubMed=21536857; DOI=10.1182/blood-2011-01-331363;
RA   Lambert A.A., Barabe F., Gilbert C., Tremblay M.J.;
RT   "DCIR-mediated enhancement of HIV-1 infection requires the ITIM-associated
RT   signal transduction pathway.";
RL   Blood 117:6589-6599(2011).
RN   [9] {ECO:0007744|PDB:5B1W, ECO:0007744|PDB:5B1X}
RP   X-RAY CRYSTALLOGRAPHY (2.90 ANGSTROMS) OF 106-237 IN COMPLEX WITH CALCIUM;
RP   MANNOSE AND N-ACETYL-D-GLUCOSAMINE, AND DISULFIDE BOND.
RX   PubMed=27015765; DOI=10.1002/1873-3468.12162;
RA   Nagae M., Ikeda A., Hanashima S., Kojima T., Matsumoto N., Yamamoto K.,
RA   Yamaguchi Y.;
RT   "Crystal structure of human dendritic cell inhibitory receptor C-type
RT   lectin domain reveals the binding mode with N-glycan.";
RL   FEBS Lett. 590:1280-1288(2016).
CC   -!- FUNCTION: C-type lectin receptor that binds carbohydrates mannose and
CC       fucose but also weakly interacts with N-acetylglucosamine (GlcNAc) in a
CC       Ca(2+)-dependent manner (PubMed:27015765). Involved in regulating
CC       immune reactivity (PubMed:18258799, PubMed:10438934). Once triggered by
CC       antigen, it is internalized by clathrin-dependent endocytosis and
CC       delivers its antigenic cargo into the antigen presentation pathway
CC       resulting in cross-priming of CD8(+) T cells. This cross-presentation
CC       and cross-priming are enhanced by TLR7 and TLR8 agonists with increased
CC       expansion of the CD8(+) T cells, high production of IFNG and TNF with
CC       reduced levels of IL4, IL5 and IL13 (PubMed:18258799, PubMed:20530286).
CC       In plasmacytoid dendritic cells, inhibits TLR9-mediated IFNA and TNF
CC       production (PubMed:18258799). May be involved via its ITIM motif
CC       (immunoreceptor tyrosine-based inhibitory motifs) in the inhibition of
CC       B-cell-receptor-mediated calcium mobilization and protein tyrosine
CC       phosphorylation (PubMed:10438934). {ECO:0000269|PubMed:10438934,
CC       ECO:0000269|PubMed:18258799, ECO:0000269|PubMed:20530286,
CC       ECO:0000269|PubMed:27015765}.
CC   -!- FUNCTION: (Microbial infection) Involved in the interaction between
CC       HIV-1 virus and dendritic cells. Enhances HIV-1 binding/entry and virus
CC       infection. Requires ITIM motif-associated signal transduction pathway
CC       involving phosphatases PTPN6 and PTPN11, SYK, Src kinases and MAP
CC       kinases. {ECO:0000269|PubMed:21536857}.
CC   -!- SUBUNIT: May interact with PTPN6 via its ITIM motif.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:18258799};
CC       Single-pass type II membrane protein {ECO:0000305}; Extracellular side
CC       {ECO:0000269|PubMed:18258799}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q9UMR7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UMR7-2; Sequence=VSP_012844;
CC       Name=3; Synonyms=llirV1;
CC         IsoId=Q9UMR7-3; Sequence=VSP_041348;
CC       Name=4; Synonyms=llirV2;
CC         IsoId=Q9UMR7-4; Sequence=VSP_012842;
CC   -!- TISSUE SPECIFICITY: Expressed preferentially in hematopoietic tissues.
CC       Expressed in all circulating Ag-presenting cells such as dendritic
CC       cells, myeloid cells, monocytes, macrophages, B-cells and epidermal
CC       Langerhans cells (at protein level). Expressed in peripheral blood
CC       leukocytes, neutrophils, moderate quantities in spleen, lymph node, and
CC       bone marrow, and at very low levels in thymus.
CC       {ECO:0000269|PubMed:10438934, ECO:0000269|PubMed:11178971,
CC       ECO:0000269|PubMed:11994513, ECO:0000269|PubMed:18258799,
CC       ECO:0000269|PubMed:20530286}.
CC   -!- INDUCTION: TNF alpha, IL-1 alpha, and LPS, down-regulated expression at
CC       the surface of neutrophils (at protein level) (PubMed:11994513).
CC       Expression is decreased in dendritic cells by signals inducing their
CC       maturation (e.g. CD40 ligand, TLR9 ligands, LPS, and TNF alpha)
CC       (PubMed:10438934, PubMed:18258799). Isoform 2: mRNA expression is up-
CC       regulated by agonists of neutrophils CSF2/GM-CSF, IL3/interleukin-3,
CC       IL4/interleukin-4 and IL13/interleukin-13 (PubMed:11994513).
CC       {ECO:0000269|PubMed:10438934, ECO:0000269|PubMed:11994513,
CC       ECO:0000269|PubMed:18258799}.
CC   -!- DOMAIN: Contains 1 copy of a cytoplasmic motif that is referred to as
CC       the immunoreceptor tyrosine-based inhibitor motif (ITIM). This motif is
CC       involved in modulation of cellular responses. The phosphorylated ITIM
CC       motif can bind the SH2 domain of several SH2-containing phosphatases
CC       (PubMed:20530286). Involved in the interaction between HIV-1 virus and
CC       dendritic cells. Enhances HIV-1 binding/entry and virus infection.
CC       Requires ITIM motif-associated signal transduction pathway involving
CC       phosphatases PTPN6 and PTPN11, SYK, Src kinases and MAP kinases
CC       (PubMed:20530286). ITIM motif-associated signal transduction pathway
CC       involving phosphatases PTPN6 and PTPN11, SYK, Src kinases and MAP
CC       kinases is required for HIV-1 binding/entry and virus infection
CC       (PubMed:20530286). {ECO:0000269|PubMed:20530286}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAL56016.1; Type=Frameshift; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - Glycan Binding;
CC       Note=DCIR;
CC       URL="http://www.functionalglycomics.org/glycomics/GBPServlet?&operationType=view&cbpId=cbp_hum_Ctlect_00137";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ133532; CAB54001.1; -; mRNA.
DR   EMBL; AF067800; AAF75560.1; -; mRNA.
DR   EMBL; AF328684; AAL56016.1; ALT_FRAME; mRNA.
DR   EMBL; AF109146; AAF14348.1; -; mRNA.
DR   EMBL; AF200738; AAG35593.1; -; mRNA.
DR   EMBL; AC006511; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC092111; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC074822; AAH74822.1; -; mRNA.
DR   EMBL; BC074874; AAH74874.1; -; mRNA.
DR   EMBL; BC117439; AAI17440.1; -; mRNA.
DR   EMBL; BC117441; AAI17442.1; -; mRNA.
DR   CCDS; CCDS41745.1; -. [Q9UMR7-3]
DR   CCDS; CCDS8590.1; -. [Q9UMR7-1]
DR   CCDS; CCDS8591.1; -. [Q9UMR7-4]
DR   CCDS; CCDS8592.1; -. [Q9UMR7-2]
DR   PIR; JC7608; JC7608.
DR   RefSeq; NP_057268.1; NM_016184.3. [Q9UMR7-1]
DR   RefSeq; NP_919429.2; NM_194447.2. [Q9UMR7-3]
DR   RefSeq; NP_919430.1; NM_194448.2. [Q9UMR7-4]
DR   RefSeq; NP_919432.1; NM_194450.2. [Q9UMR7-2]
DR   PDB; 5B1W; X-ray; 3.05 A; A/B/C/D=106-237.
DR   PDB; 5B1X; X-ray; 2.90 A; A/B/C/D=106-237.
DR   PDBsum; 5B1W; -.
DR   PDBsum; 5B1X; -.
DR   AlphaFoldDB; Q9UMR7; -.
DR   SMR; Q9UMR7; -.
DR   BioGRID; 119158; 114.
DR   STRING; 9606.ENSP00000229332; -.
DR   UniLectin; Q9UMR7; -.
DR   GlyGen; Q9UMR7; 1 site.
DR   iPTMnet; Q9UMR7; -.
DR   PhosphoSitePlus; Q9UMR7; -.
DR   BioMuta; CLEC4A; -.
DR   DMDM; 59797977; -.
DR   jPOST; Q9UMR7; -.
DR   MassIVE; Q9UMR7; -.
DR   PaxDb; Q9UMR7; -.
DR   PeptideAtlas; Q9UMR7; -.
DR   PRIDE; Q9UMR7; -.
DR   ProteomicsDB; 85200; -. [Q9UMR7-1]
DR   ProteomicsDB; 85201; -. [Q9UMR7-2]
DR   ProteomicsDB; 85202; -. [Q9UMR7-3]
DR   ProteomicsDB; 85203; -. [Q9UMR7-4]
DR   ABCD; Q9UMR7; 1 sequenced antibody.
DR   Antibodypedia; 1471; 330 antibodies from 25 providers.
DR   DNASU; 50856; -.
DR   Ensembl; ENST00000229332.12; ENSP00000229332.5; ENSG00000111729.15. [Q9UMR7-1]
DR   Ensembl; ENST00000345999.9; ENSP00000344646.3; ENSG00000111729.15. [Q9UMR7-4]
DR   Ensembl; ENST00000352620.9; ENSP00000247243.5; ENSG00000111729.15. [Q9UMR7-2]
DR   Ensembl; ENST00000360500.5; ENSP00000353690.3; ENSG00000111729.15. [Q9UMR7-3]
DR   GeneID; 50856; -.
DR   KEGG; hsa:50856; -.
DR   MANE-Select; ENST00000229332.12; ENSP00000229332.5; NM_016184.4; NP_057268.1.
DR   UCSC; uc001qtz.1; human. [Q9UMR7-1]
DR   CTD; 50856; -.
DR   DisGeNET; 50856; -.
DR   GeneCards; CLEC4A; -.
DR   HGNC; HGNC:13257; CLEC4A.
DR   HPA; ENSG00000111729; Tissue enhanced (bone marrow, lymphoid tissue).
DR   MIM; 605306; gene.
DR   neXtProt; NX_Q9UMR7; -.
DR   OpenTargets; ENSG00000111729; -.
DR   PharmGKB; PA26584; -.
DR   VEuPathDB; HostDB:ENSG00000111729; -.
DR   eggNOG; KOG4297; Eukaryota.
DR   GeneTree; ENSGT00940000158835; -.
DR   HOGENOM; CLU_049894_10_2_1; -.
DR   InParanoid; Q9UMR7; -.
DR   OMA; ASATFWH; -.
DR   OrthoDB; 1378771at2759; -.
DR   PhylomeDB; Q9UMR7; -.
DR   TreeFam; TF333341; -.
DR   PathwayCommons; Q9UMR7; -.
DR   Reactome; R-HSA-5621480; Dectin-2 family.
DR   SignaLink; Q9UMR7; -.
DR   BioGRID-ORCS; 50856; 8 hits in 1066 CRISPR screens.
DR   ChiTaRS; CLEC4A; human.
DR   GeneWiki; CLEC4A; -.
DR   GenomeRNAi; 50856; -.
DR   Pharos; Q9UMR7; Tbio.
DR   PRO; PR:Q9UMR7; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q9UMR7; protein.
DR   Bgee; ENSG00000111729; Expressed in monocyte and 98 other tissues.
DR   ExpressionAtlas; Q9UMR7; baseline and differential.
DR   Genevisible; Q9UMR7; HS.
DR   GO; GO:0009897; C:external side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005509; F:calcium ion binding; IDA:UniProtKB.
DR   GO; GO:0030246; F:carbohydrate binding; IDA:UniProtKB.
DR   GO; GO:0005537; F:mannose binding; IDA:UniProtKB.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; TAS:ProtInc.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0061760; P:antifungal innate immune response; IBA:GO_Central.
DR   GO; GO:0042590; P:antigen processing and presentation of exogenous peptide antigen via MHC class I; IDA:UniProtKB.
DR   GO; GO:0036037; P:CD8-positive, alpha-beta T cell activation; IDA:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc.
DR   GO; GO:0006955; P:immune response; IBA:GO_Central.
DR   GO; GO:0001818; P:negative regulation of cytokine production; IDA:UniProtKB.
DR   GO; GO:0032720; P:negative regulation of tumor necrosis factor production; IDA:UniProtKB.
DR   GO; GO:0002470; P:plasmacytoid dendritic cell antigen processing and presentation; IDA:UniProtKB.
DR   CDD; cd03590; CLECT_DC-SIGN_like; 1.
DR   Gene3D; 3.10.100.10; -; 1.
DR   InterPro; IPR001304; C-type_lectin-like.
DR   InterPro; IPR016186; C-type_lectin-like/link_sf.
DR   InterPro; IPR018378; C-type_lectin_CS.
DR   InterPro; IPR033989; CD209-like_CTLD.
DR   InterPro; IPR016187; CTDL_fold.
DR   Pfam; PF00059; Lectin_C; 1.
DR   SMART; SM00034; CLECT; 1.
DR   SUPFAM; SSF56436; SSF56436; 1.
DR   PROSITE; PS00615; C_TYPE_LECTIN_1; 1.
DR   PROSITE; PS50041; C_TYPE_LECTIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Adaptive immunity; Alternative splicing; Calcium;
KW   Cell membrane; Disulfide bond; Glycoprotein; Host-virus interaction;
KW   Immunity; Innate immunity; Lectin; Membrane; Metal-binding;
KW   Reference proteome; Signal-anchor; Transmembrane; Transmembrane helix.
FT   CHAIN           1..237
FT                   /note="C-type lectin domain family 4 member A"
FT                   /id="PRO_0000046612"
FT   TOPO_DOM        1..48
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        49..69
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        70..237
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          113..231
FT                   /note="C-type lectin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   MOTIF           5..10
FT                   /note="ITIM motif"
FT                   /evidence="ECO:0000269|PubMed:20530286"
FT   BINDING         143
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:27015765,
FT                   ECO:0007744|PDB:5B1W, ECO:0007744|PDB:5B1X"
FT   BINDING         145
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:27015765,
FT                   ECO:0007744|PDB:5B1W, ECO:0007744|PDB:5B1X"
FT   BINDING         149
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:27015765,
FT                   ECO:0007744|PDB:5B1W, ECO:0007744|PDB:5B1X"
FT   BINDING         195..197
FT                   /ligand="alpha-D-mannopyranose"
FT                   /ligand_id="ChEBI:CHEBI:28729"
FT                   /evidence="ECO:0000269|PubMed:27015765,
FT                   ECO:0007744|PDB:5B1X"
FT   BINDING         195
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:27015765,
FT                   ECO:0007744|PDB:5B1W, ECO:0007744|PDB:5B1X"
FT   BINDING         197
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:27015765,
FT                   ECO:0007744|PDB:5B1W, ECO:0007744|PDB:5B1X"
FT   BINDING         201
FT                   /ligand="alpha-D-mannopyranose"
FT                   /ligand_id="ChEBI:CHEBI:28729"
FT                   /evidence="ECO:0000269|PubMed:27015765,
FT                   ECO:0007744|PDB:5B1X"
FT   BINDING         201
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:27015765,
FT                   ECO:0007744|PDB:5B1W, ECO:0007744|PDB:5B1X"
FT   BINDING         207..209
FT                   /ligand="N-acetyl-D-glucosamine"
FT                   /ligand_id="ChEBI:CHEBI:506227"
FT                   /evidence="ECO:0000269|PubMed:27015765,
FT                   ECO:0007744|PDB:5B1X"
FT   BINDING         218
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:27015765,
FT                   ECO:0007744|PDB:5B1W, ECO:0007744|PDB:5B1X"
FT   BINDING         219
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:27015765,
FT                   ECO:0007744|PDB:5B1W, ECO:0007744|PDB:5B1X"
FT   BINDING         231
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:27015765,
FT                   ECO:0007744|PDB:5B1W, ECO:0007744|PDB:5B1X"
FT   CARBOHYD        185
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        106..117
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040,
FT                   ECO:0000269|PubMed:27015765, ECO:0007744|PDB:5B1W,
FT                   ECO:0007744|PDB:5B1X"
FT   DISULFID        134..230
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040,
FT                   ECO:0000269|PubMed:27015765, ECO:0007744|PDB:5B1W,
FT                   ECO:0007744|PDB:5B1X"
FT   DISULFID        203..222
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040,
FT                   ECO:0000269|PubMed:27015765, ECO:0007744|PDB:5B1W,
FT                   ECO:0007744|PDB:5B1X"
FT   VAR_SEQ         28..99
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:11178971"
FT                   /id="VSP_012842"
FT   VAR_SEQ         28..67
FT                   /note="ASKERTAPHKSNTGFPKLLCASLLIFFLLLAISFFIAFVI -> V (in
FT                   isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:11178971"
FT                   /id="VSP_041348"
FT   VAR_SEQ         67..100
FT                   /note="IFFQKYSQLLEKKTTKELVHTTLECVKKNMPVEE -> K (in isoform
FT                   2)"
FT                   /evidence="ECO:0000303|PubMed:11994513"
FT                   /id="VSP_012844"
FT   VARIANT         36
FT                   /note="H -> L (in dbSNP:rs2024301)"
FT                   /evidence="ECO:0000269|PubMed:11178971,
FT                   ECO:0000269|PubMed:11994513, ECO:0000269|PubMed:15489334"
FT                   /id="VAR_021260"
FT   MUTAGEN         6
FT                   /note="T->F: Decreases HIV-1 binding/entry in cells as well
FT                   as virus replication."
FT                   /evidence="ECO:0000269|PubMed:21536857"
FT   MUTAGEN         7
FT                   /note="Y->F: Decreases HIV-1 binding/entry in cells as well
FT                   as virus replication."
FT                   /evidence="ECO:0000269|PubMed:21536857"
FT   CONFLICT        130
FT                   /note="S -> C (in Ref. 4; AAF75560)"
FT                   /evidence="ECO:0000305"
FT   STRAND          111..113
FT                   /evidence="ECO:0007829|PDB:5B1X"
FT   STRAND          116..120
FT                   /evidence="ECO:0007829|PDB:5B1X"
FT   HELIX           127..136
FT                   /evidence="ECO:0007829|PDB:5B1X"
FT   HELIX           147..154
FT                   /evidence="ECO:0007829|PDB:5B1X"
FT   STRAND          163..168
FT                   /evidence="ECO:0007829|PDB:5B1X"
FT   STRAND          172..174
FT                   /evidence="ECO:0007829|PDB:5B1X"
FT   HELIX           186..188
FT                   /evidence="ECO:0007829|PDB:5B1X"
FT   STRAND          203..209
FT                   /evidence="ECO:0007829|PDB:5B1X"
FT   TURN            210..213
FT                   /evidence="ECO:0007829|PDB:5B1X"
FT   STRAND          214..220
FT                   /evidence="ECO:0007829|PDB:5B1X"
FT   STRAND          222..224
FT                   /evidence="ECO:0007829|PDB:5B1X"
FT   STRAND          226..233
FT                   /evidence="ECO:0007829|PDB:5B1X"
SQ   SEQUENCE   237 AA;  27512 MW;  1D07003E4C9CF96E CRC64;
     MTSEITYAEV RFKNEFKSSG INTASSAASK ERTAPHKSNT GFPKLLCASL LIFFLLLAIS
     FFIAFVIFFQ KYSQLLEKKT TKELVHTTLE CVKKNMPVEE TAWSCCPKNW KSFSSNCYFI
     STESASWQDS EKDCARMEAH LLVINTQEEQ DFIFQNLQEE SAYFVGLSDP EGQRHWQWVD
     QTPYNESSTF WHPREPSDPN ERCVVLNFRK SPKRWGWNDV NCLGPQRSVC EMMKIHL
//
